SLFN11-POSITIVE

Clinical trials for SLFN11-POSITIVE explained in plain language.

Never miss a new study

Get alerted when new SLFN11-POSITIVE trials appear

Sign up with your email to follow new studies for SLFN11-POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for Tough-to-Treat lung cancer: drug combo trial seeks to extend remission

Disease control Recruiting now

This trial is testing whether adding a drug called niraparib to standard immunotherapy maintenance can help control advanced small cell lung cancer for longer. It is for patients whose cancer has a specific biomarker (SLFN11-positive) and has not worsened after initial chemothera…

Matched conditions: SLFN11-POSITIVE

Phase: PHASE2 • Sponsor: ETOP IBCSG Partners Foundation • Aim: Disease control

Last updated Mar 23, 2026 15:18 UTC

SLFN11-POSITIVE

Get alerted when new SLFN11-POSITIVE trials appear

New hope for Tough-to-Treat lung cancer: drug combo trial seeks to extend remission